The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Abstract
Bisphosphonates inhibit bone resorption and are therapeutically effective in diseases of increased bone turnover, such as Paget's disease and hypercalcemia of malignancy. The mechanisms by which they act remain unclear. Proposed mechanisms include inhibition of osteoclast formation from precursors and inhibitory or toxic effects on mature osteoclasts. We have developed a new in vitro model to study osteoclast survival and in this paper present in vitro and in vivo evidence that may explain both the observed reduction in osteoclast numbers and in bone resorption by mature osteoclasts, namely that bisphosphonates induce programmed cell death (apoptosis). Three bisphosphonates (risedronate, pamidronate, and clodronate) caused a 4- to 24-fold increase in the proportion of osteoclasts showing the characteristic morphology of apoptosis in vitro. This observation was confirmed in vivo in normal mice, in mice with increased bone resorption, and in nude mice with osteolytic cancer metastases, with similar-fold increases to those observed in vitro. Of the three compounds, risedronate, the most potent inhibitor of bone resorption in vivo, was the strongest inducer of osteoclast apoptosis in vitro. Osteoclast apoptosis may therefore be a major mechanism whereby bisphosphonates reduce osteoclast numbers and activity, and induction of apoptosis could be a therapeutic goal for new antiosteoclast drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function
Minkin, C. (1982) · Calcified Tissue International · doi:10.1007/bf02411252 · Cited by 990
Storm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Molecular regulation of apoptosis: Genetic controls on cell death
Williams, G. T., & Smith, C. A. (1993) · Cell · doi:10.1016/0092-8674(93)90457-2 · Cited by 895
TAKAHASHI, N., YAMANA, H., YOSHIKI, S., ROODMAN, G. D., MUNDY, G. R., JONES, S. J., BOYDE, A., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 730
Self-citationFleisch, H. (1991) · Drugs · doi:10.2165/00003495-199142060-00003 · Cited by 581
Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.
Boyce, B. F., Yoneda, T., Lowe, C., Soriano, P., & Mundy, G. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116032 · Cited by 550
Self-citationCartilage-inducing factor-A. Apparent identity to transforming growth factor-beta.
Seyedin, S. M., Thompson, A. Y., Bentz, H., Rosen, D. M., McPherson, J. M., Conti, A., Siegel, N. R., Galluppi, G. R., & Piez, K. A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38436-3 · Cited by 521
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Schenk, R., Merz, W. A., Mühlbauer, R., Russell, R. G. G., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547219 · Cited by 482
Bursch, W., Paffe, S., Putz, B., Barthel, G., & Schulte-Hermann, R. (1990) · Carcinogenesis · doi:10.1093/carcin/11.5.847 · Cited by 444
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki, A., Boyce, B. F., Story, B. M., Wright, K. R., Chapman, M., Boyce, R. W., Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 417
Self-citationBisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni, M., Guenther, H. L., Fleisch, H., Collin, P., & Martin, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116422 · Cited by 412
Bone and mineral research: Annual 2
(1985) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(85)90318-0 · Cited by 407
The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
Jung, A., Bisaz, S., & Fleisch, H. (1973) · Calcified Tissue Research · doi:10.1007/bf02547227 · Cited by 381
Effects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
Self-citationFuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R., & Chambers, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1733 · Cited by 362
Nitric Oxide Synthase Induces Macrophage Death by Apoptosis
Sarih, M., Souvannavong, V., & Adam, A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1246 · Cited by 357
A murine model of experimental metastasis to bone and bone marrow.
Arguello, F., Baggs, R. B., & Frantz, C. N. (1988) · PubMed · Cited by 357
Hughes, D. E., MacDonald, B. R., Russell, R. G., & Gowen, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114100 · Cited by 357
Self-citationTwo modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Rotello, R. J., Lieberman, R. C., Purchio, A. F., & Gerschenson, L. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3412 · Cited by 275
Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
Sato, M., & Grasser, W. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050107 · Cited by 264
Altman, R. D., Johnston, C. C., Khairi, M. R. A., Wellman, H., Serafini, A. N., & Sankey, R. R. (1973) · New England Journal of Medicine · doi:10.1056/nejm197312272892601 · Cited by 248
Lotem, J., & Sachs, L. (1992) · Blood · doi:10.1182/blood.v80.7.1750.1750 · Cited by 196
Flanagan, A. M., & Chambers, T. J. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90021-4 · Cited by 195
DIPHOSPHONATES IN PAGET'S DISEASE
Russell, R. G. G., Preston, C., Smith, R., Walton, R. J., & Woods, C. G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90347-x · Cited by 177
Transforming growth factor-β 1 as a signal for induction of cell death by apoptosis
Bursch, W., Oberhammer, F., Jirtle, R., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A., & Schulte-Hermann, R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.98 · Cited by 172
Flanagan, A. M., & Chambers, T. J. (1991) · Calcified Tissue International · doi:10.1007/bf02555852 · Cited by 171
TAKAHASHI, N., AKATSU, T., SASAKI, T., NICHOLSON, G. C., MOSELEY, J. M., JOHN MARTIN, T., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-123-3-1504 · Cited by 168
Zanovello, P., Bronte, V, Rosato, A., Pizzo, P., & Di Virgilio, F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1545 · Cited by 158
Johnson, R., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1989) · Endocrinology · doi:10.1210/endo-124-3-1424 · Cited by 152
Self-citationEffect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages
Cecchini, M. G., Felix, R., Fleisch, H. A., & Cooper, P. H. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020209 · Cited by 144
Antiresorptive dose-response relationships across three generations of bisphosphonates.
Sietsema, W. K., Ebetino, F. H., Salvagno, A. M., & Bevan, J. A. (1989) · PubMed · Cited by 139
Arends, M., McGregor, A. H., Toft, N. J., Brown, E., & Wyllie, A. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.492 · Cited by 120
Reitsma, P. H., Teitelbaum, S. L., Bijvoet, O. L. M., & Kahn, A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110704 · Cited by 120
Nakai, M., Mundy, G. R., Williams, P. J., et al. (1992) · PubMed · Cited by 105
Self-citationCecchini, M. G., & Fleisch, H. A. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051005 · Cited by 94
Bisphosphonates : Mechanisms of Action and Clinical Applications
Fleisch, H. A. (1983) · Medical Entomology and Zoology · Cited by 76
Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages
Stevenson, P. H., & Stevenson, J. R. (1986) · Calcified Tissue International · doi:10.1007/bf02556715 · Cited by 74
Diphosphonates inhibit bone resorption by macrophages in vitro
Chambers, T. J. (1980) · The Journal of Pathology · doi:10.1002/path.1711320307 · Cited by 72
Lerner, U. H., & Larsson, Å. (1987) · Bone · doi:10.1016/8756-3282(87)90018-4 · Cited by 47
Boyce, B. F., Wright, K., Reddy, S. V., et al. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588333 · Cited by 46
Self-citationThe cellular mechanism of action of bisphosphonates.
Hughes, D., Mian, M., Guilland-Cumming, D. F., & Russell, R. G. G. (1991) · PubMed · Cited by 40
Self-citationStutzer, A., Fleisch, H. A., & Trechsel, U. (1988) · Calcified Tissue International · doi:10.1007/bf02556639 · Cited by 32
Effects of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts.
Dr. Marshall, M. J., Wilson, A. S., & Davie, M. W. J. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050909 · Cited by 23
Research works printed but not linked: 6
- Fleisch, 1993, Prospective use of bisphosphonates in osteoporosis, J Clin Endocrinol Metab, 76, 1397
- Sasaki, 1989, Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1,25-dihydroxyvitamin D3 have ruffled borders and resorb bone, Anat Rec, 224, 379, 10.1002/ar.1092240307 · doi:10.1002/ar.1092240307
- Fouda, 1989, Developmental disturbances of the rat molar induced by two diphosphonates, Adv Dent Res, 3, 234, 10.1177/08959374890030022401 · doi:10.1177/08959374890030022401
- Uy, 1994, Risedronate affects mature osteoclasts (ocl) but not ocl precursors in vivo, J Bone Miner Res, 9, S242
- Pioli, 1990, Bisphosphonates stimulate the production of cytokines by human peripheral blood mononuclear cells in vitro, Calcif Tissue Int, 46, A54
- Hughes, 1994, TGFβ1 induces osteoclast apoptosis in vitro, J Bone Miner Res, 9, S138
Cited by
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Self-citationBisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
Metadata
- Authors
- Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-10-01
- Volume
- 10
- Issue
- 10
- Pages
- 1478-1487
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2161690532
- Cited by
- 1,040
- References
- 49
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- NIH (DE 08569, CA 40035, AR-41336)
- American Cancer Society (IRG-116)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.